Skip to Main Content

Paper Details

Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria, Swiss AGO, BGOG, CEEGOG, GEICO, and SFOG regarding the use of hyperthermic intraperitoneal chemotherapy (HIPEC) in epithelial ovarian cancer.
Bull Cancer
2
2024
Author NameAffiliation
Fr??d??ric AmantGeneral University Hospital in Prague, Charles University
Sven MahnerUniversity Hospital
Isabelle Ray-Coquard
  • 1 - 3

Datasets

Release 1.2